Kuros Biosciences AG (SWX: KURN)

Kuros Biosciences AG Balance Sheet

Financials in millions CHF. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	99.08	126.88	137.75	83.25	93.87	127.42
Short-Term Investments	-	-	-	0.5	0.5	0.9
Cash & Short-Term Investments	99.08	126.88	137.75	83.75	94.37	128.32
Cash Growth	4.59%	-7.89%	64.48%	-11.26%	-26.46%	-6.81%
Accounts Receivable	27.2	84	65.37	51.06	33.96	48.47
Other Receivables	11.39	13.65	12.81	23.56	44.56	19.98
Receivables	38.59	97.65	78.18	74.62	78.52	68.45
Inventory	86.24	96.95	117.97	31.45	33.57	51.56
Prepaid Expenses	20.26	17.29	18.41	11.27	10.88	11.5
Other Current Assets	-	-	0.05	0.41	0.62	0.63
Total Current Assets	244.16	338.78	352.35	201.49	217.96	260.46
Property, Plant & Equipment	43.75	43.44	46.65	43.29	42.52	34.53
Long-Term Investments	0.43	0.47	0.58	0.78	7.82	8.84
Goodwill	54.62	52.69	55.62	58.22	59.91	56.03
Other Intangible Assets	152.48	5.91	10.06	14.08	13.55	19.33
Long-Term Deferred Tax Assets	14.67	8.9	8.31	9.19	11.67	6.89
Long-Term Deferred Charges	-	141.21	193.39	176.36	163.28	199.87
Other Long-Term Assets	1.3	1.7	1.66	1.07	1.19	-
Total Assets	511.42	593.11	668.62	504.47	517.9	585.94
Accounts Payable	13.44	31.37	60.68	25	17.77	25.42
Accrued Expenses	17.94	28.14	44.13	37.14	21.23	21.53
Short-Term Debt	-	40.7	-	-	-	-
Current Portion of Long-Term Debt	-	-	59.97	-	59.96	-
Current Portion of Leases	5.76	5.04	5.55	5.39	4.73	5.31
Current Income Taxes Payable	5.16	5.27	7.19	1.85	0.88	0.67
Other Current Liabilities	21.56	16.88	12.59	10.12	7.53	8.5
Total Current Liabilities	63.87	127.39	190.11	79.49	112.11	61.43
Long-Term Debt	-	-	-	59.84	60.72	119.42
Long-Term Leases	26.85	26.84	29.54	27.4	28.26	16.87
Long-Term Deferred Tax Liabilities	5.63	5.74	11.48	1.46	1.56	6.94
Other Long-Term Liabilities	16.94	16.47	14.59	13	8	8.38
Total Liabilities	128.39	191.25	256.63	202.46	235.22	234.34
Common Stock	77.52	83.59	96.84	105.3	105.3	109.57
Additional Paid-In Capital	42.24	32.92	23.18	16.6	16.6	16.6
Retained Earnings	297.67	325.92	347.52	234.75	212.33	274.99
Treasury Stock	-1.69	-3.52	-27.71	-31.92	-31.92	-32.03
Comprensive Income & Other	-32.71	-37.05	-27.84	-22.72	-19.77	-17.66
Total Common Equity	383.03	401.86	412	302.01	282.55	351.46
Minority Interest	-	-	-	-	0.14	0.14
Shareholders' Equity	383.03	401.86	412	302.01	282.69	351.6
Total Liabilities & Equity	511.42	593.11	668.62	504.47	517.9	585.94
Total Debt	32.61	72.58	95.05	92.63	153.67	141.6
Net Cash (Debt)	66.47	54.31	42.7	-8.89	-59.3	-13.28
Net Cash Growth	220.34%	27.19%	-	-	-	-
Net Cash Per Share	9.14	7.62	6.01	-1.28	-8.55	-1.92
Filing Date Shares Outstanding	7.35	7.25	7.02	6.94	6.94	6.94
Total Common Shares Outstanding	7.35	7.25	7.02	6.94	6.94	6.94
Working Capital	180.3	211.39	162.25	122	105.85	199.03
Book Value Per Share	52.13	55.44	58.71	43.54	40.73	50.67
Tangible Book Value	175.93	343.26	346.32	229.72	209.09	276.11
Tangible Book Value Per Share	23.95	47.35	49.35	33.12	30.14	39.80
Machinery	-	79.67	76.32	80.23	75.4	72.48

Source: S&P Capital IQ. Standard template. Financial Sources.